Amyotrophic lateral sclerosis

  title={Amyotrophic lateral sclerosis},
  author={M. V. Es and O. Hardiman and A. Chi{\`o} and A. Al-Chalabi and L. Berg},
  journal={The Lancet},
  • M. V. Es, O. Hardiman, +2 authors L. Berg
  • Published 2017
  • Medicine
  • The Lancet
  • Amyotrophic lateral sclerosis is characterised by the progressive loss of motor neurons in the brain and spinal cord. This neurodegenerative syndrome shares pathobiological features with frontotemporal dementia and, indeed, many patients show features of both diseases. Many different genes and pathophysiological processes contribute to the disease, and it will be necessary to understand this heterogeneity to find effective treatments. In this Seminar, we discuss clinical and diagnostic… CONTINUE READING
    18 Citations

    Figures, Tables, and Topics from this paper

    Explore Further: Topics Discussed in This Paper

    Paper Mentions

    Interventional Clinical Trial
    Given the role of adaptive immunity in ALS, the pathogenicity of some clostridial strains on motorneurons, the putative role of cyanobacteria in ALS development, and the increasing… Expand
    ConditionsAmyotrophic Lateral Sclerosis
    Interventional Clinical Trial
    The purpose of this research is to investigate the validity of a previous clinical trial named EH301, which showed beneficial effects of anti-oxidant therapies in patients with… Expand
    ConditionsAmyotrophic Lateral Sclerosis (ALS)
    InterventionCombination Product
    Observational Clinical Trial
    BACKGROUND/RATIONALE: The paucity of biomarkers for the diagnosis and monitoring of patients affected by Amyotrophic Lateral Sclerosis (ALS) is one of the greatest concerns in ALS… Expand
    ConditionsAmyotrophic Lateral Sclerosis
    Novel therapeutic targets for amyotrophic lateral sclerosis
    • 2
    Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study
    • 2
    Multi-Omics for Biomarker Discovery and Target Validation in Biofluids for Amyotrophic Lateral Sclerosis Diagnosis.
    • 10
    Radial diffusivity as an imaging biomarker for early diagnosis of non-demented amyotrophic lateral sclerosis
    • 4
    Neuroglia in Neurodegenerative Diseases
    • 1
    Meta-analysis of the association between ZNF512B polymorphism rs2275294 and risk of amyotrophic lateral sclerosis
    • 3


    Energy metabolism in amyotrophic lateral sclerosis
    • 353
    State of play in amyotrophic lateral sclerosis genetics
    • 1,004
    • PDF
    Cognitive and behavioral challenges in caring for patients with frontotemporal dementia and amyotrophic lateral sclerosis
    • 68
    Mutations of optineurin in amyotrophic lateral sclerosis
    • 974